
Randomly, half of the patients will have an FDA-approved AI tool assist a radiologist in analyzing the data, while the other half will go through routine screening without the AI tool. MADISON, Wis. (...
Randomly, half of the patients will have an FDA-approved AI tool assist a radiologist in analyzing the data, while the other half will go through routine screening without the AI tool. MADISON, Wis. (...